CALSTABIN
Dead / Cancelled — Cancelled — Section 8 (as of 20 Mar 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85616604
- Registration number
- 4385182
- Mark type
- Stylized text
- Filed
- 04 May 2012
- Published for opposition
- 16 Oct 2012
- Registered
- 13 Aug 2013
- Attorney of record
- William L. Bartow
Goods and services
- Class 042 — Scientific and technological services: PHARMACEUTICAL RESEARCH AND DEVELOPMENT; CUSTOM DESIGN AND DEVELOPMENT OF CHEMICAL REAGENTS AND BIOMEDICAL ASSAYS
Owner
- ARMGO Pharma, Inc., Tarrytown, NY, US
- ARMGO Pharma, Inc., Tarrytown, NY, US
- ARMGO Pharma, Inc., Tarrytown, NY, US
Prosecution history
- 20 Mar 2020 — CANCELLED SEC. 8 (6-YR)
- 13 Aug 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Aug 2013 — REGISTERED-PRINCIPAL REGISTER
- 06 Jul 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jul 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 03 Jul 2013 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jul 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2013 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jun 2013 — USE AMENDMENT FILED
- 02 Jul 2013 — SOU EXTENSION 1 GRANTED
- 05 Jun 2013 — SOU EXTENSION 1 FILED
- 28 Jun 2013 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jun 2013 — SOU TEAS EXTENSION RECEIVED
- 05 Jun 2013 — TEAS STATEMENT OF USE RECEIVED
- 11 Dec 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT